(AIM: MED ) has announced the launch of its proprietary COVID-19 training module for its BodyWorks ultrasound simulator, that is now free to existing hospital users.
COVID-19 Training Module
Ultrasound has major utility for the management of respiratory related COVID-19 disease, due to its safety, repeatability, absence of radiation, low cost, ease of disinfection and point of care use. This new training simulator, as well as the free COVID-19 upgrade training module for the Group’s existing BodyWorks customers, includes a number of examples of lung ultrasound appearances typical of COVID-19 infection to enable clinical staff to practice and train in the use of lung ultrasound for diagnosing COVID-19 infections.
The module was made available to the market yesterday and is already in use in the UK and USA.
Despite the resultant downturn in global business due to COVID-19, the Group has implemented several cost-saving measures that will maintain FY20 EBITDA broadly in line with current market expectations.
Furthermore, the Group states it will be able to meet all internal development milestones, including to generate first AI revenues in H1 2021. However, in light of the very necessary restrictions imposed in response to the pandemic, any external development or launch milestones that are not in the Group’s direct control, cannot be guaranteed.
The outlook for the medium and long term remains unchanged for the Group and we note the strong balance sheet has sufficient funds to continue its simulation and AI business activities well into 2021, when maiden revenues from its first AI software licence agreement are expected to be generated.
Over the past 12 months, shares in Intelligent Ultrasound have traded from 5.65p to close yesterday 8/.25p
Stuart Gall, Chief Executive Officer of Intelligent Ultrasound, commented: "Whilst COVID-19 is expected to have an impact on our global simulator sales, we are implementing a series of cost reductions, that we believe will be sufficient to enable the Group to continue well into 2021, when our first AI software licence revenues will come onstream. As such, the medium and longer-term prospects for our business remain unchanged."
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
EquityBytes - The Vox Markets Sponsored Research platform – Finds Dev Clever could generate over £26m revenue to FY24. Current EV/Sales market multiples, for similar Virtual Reality /SaaS based technology companies in the UK of circa. 4x, suggests shareholders could benefit from a significant re-rating of the stock over the next four years.
Some 20,000 former NHS staff have returned to work to help the fight against coronavirus, Boris Johnson has revealed in a video posted online. The prime minister, who is self-isolating after testing positive for the virus, said the country would get through the crisis "together".
SP Angel . Morning View. China $344bn stimulus to help economy
City Pub Group (CPC) has announced it has successfully raised £15m at 50p. The Company also intends to raise up to a further £7million through an open offer for Private Investors.
Keystone Law (AIM:KEYS) has said it is in ‘a strong position’ to deal with the financial and operational impact of the COVID-19 global pandemic. Trading for 2020 is in-line with expectations for the six weeks ended 31 January.